IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study

Detalles Bibliográficos
Autores principales: Kubica, Jacek, Podhajski, Przemysław, Magielski, Przemysław, Kubica, Aldona, Adamski, Piotr, Junik, Roman, Pinkas, Jarosław, Navarese, Eliano P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890419/
https://www.ncbi.nlm.nih.gov/pubmed/34787891
http://dx.doi.org/10.5603/CJ.a2021.0148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890419/
https://www.ncbi.nlm.nih.gov/pubmed/34787891
http://dx.doi.org/10.5603/CJ.a2021.0148

Ejemplares similares